Mayne Pharma Group (AU:MYX) has released an update.
Mayne Pharma Group Limited has announced the cessation of 12,431 performance rights due to the non-fulfillment of conditions required for their continuation. The ceased securities were reported to the Australian Securities Exchange (ASX) under the code MYXAN, with the cessation date being August 25, 2024. This is a new announcement made by the company on August 28, 2024.
For further insights into AU:MYX stock, check out TipRanks’ Stock Analysis page.
